I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1..:
Luigi Tortola (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA))
;
Roberto Nitsch (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA))
;
Mathieu J.M. Bertrand (Inflammation Research Center, VIB)
...
isPartOf:https://phaidra.univie.ac.at/o:243553[u:scholar collection]. , 2016
Link:
https://doi.org/10.1016/j.celrep.2016.04.032
RT Journal T1
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
UL https://suche.suub.uni-bremen.de/peid=base-ftunivwiendc:oai:phaidra.univie.ac.at:o:527591&Exemplar=1&LAN=DE A1 Luigi Tortola (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Roberto Nitsch (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Mathieu J.M. Bertrand (Inflammation Research Center, VIB) A1 Melanie Kogler (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Younes Redouane (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Ivona Kozieradzki (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Iris Uribesalgo (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Lilian M. Fennell (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Mads Daugaard (Vancouver Prostate Centre) A1 Helene Klug (Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics) A1 Gerald Wirnsberger (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Reiner Wimmer (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Thomas Perlot (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Renu Sarao (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Shuan Rao (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Toshikatsu Hanada (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Nozomi Takahashi (Inflammation Research Center, VIB) A1 Elisabeth Kernbauer (Max F. Perutz Laboratories, Universität Wien) A1 Duygu Demiröz (Max F. Perutz Laboratories, Universität Wien) A1 Michaela Lang (Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Christian Doppler Laboratory for Molecular Cancer Chemoprevention, Medical University of Vienna) A1 Giulio Superti-Furga (CEMM, Centre for Molecular Medicine) A1 Thomas Decker (Max F. Perutz Laboratories, Universität Wien) A1 Andrea Pichler (Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics) A1 Fumiyo Ikeda (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) A1 Guido Kroemer (INSERM U848) A1 Peter Vandenabeele (Inflammation Research Center, VIB) A1 Poul H. Sorensen (Department of Molecular Oncology, BC Cancer Research Center, University of British Columbia) A1 Josef M. Penninger (Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)) PB Elsevier BV YR 2016 JF isPartOf:https://phaidra.univie.ac.at/o:243553[u:scholar collection] LK http://dx.doi.org/https://doi.org/10.1016/j.celrep.2016.04.032 DO https://doi.org/10.1016/j.celrep.2016.04.032 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)